GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$49.58
Price-2.71%
-$1.38
1Y
Price
Market Cap
$99.710b
Large
Price/Earnings 3y Avg5y Avg
12.8x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in GBP.+36.4%
EBITDA Margin+22.8%
Net Profit Margin+9.2%
Free Cash Flow Margin+36.4%
EBITDA Margin+22.8%
Net Profit Margin+9.2%
Free Cash Flow MarginRevenue
$32.780b
+0.4%
1y CAGR+2.6%
3y CAGR+2.8%
5y CAGREarnings
$5.829b
+2.0%
1y CAGR+25.4%
3y CAGR+2.3%
5y CAGREPS
$3.36
-39.6%
1y CAGR+86.8%
3y CAGR+65.1%
5y CAGRBook Value
$22.974b
$82.905b
Assets$59.931b
Liabilities$25.129b
DebtDebt to Assets
30.3%
2.2x
Debt to EBITDAFree Cash Flow
$6.236b
+7.1%
1y CAGR+9.1%
3y CAGR+5.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company